Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-Naive Patients With Moderately-to-Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Multicenter, Multi-Country, Randomized, Double-Blind, Active Comparator–Controlled Trial

Ronald van Vollenhoven, Tsutomu Takeuchi, Aileen L. Pangan, Alan Friedman, Mohamed Eslam F. Mohamed, Su Chen, Maureen Rischmueller, Ricardo Blanco, Ricardo M. Xavier, Vibeke Strand

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Fingerprint Dive into the research topics of 'Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-Naive Patients With Moderately-to-Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Multicenter, Multi-Country, Randomized, Double-Blind, Active Comparator–Controlled Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences